Income Statement Balance Sheet Cash Flow Statement
Annual Financials for NanoViricides Inc.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 95,289 527,742 - 219,651 212,009
COGS excluding D&A 0 0 - 0 0
Depreciation & Amortization Expense 95,289 527,742 219,653 219,651 212,009
Depreciation 86,514 518,967 210,877 210,877 203,234
Amortization of Intangibles 8,775 8,775 8,776 8,774 8,775
Gross Income (95,289) (527,742) - (219,651) (212,009)
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 5.01M 5.9M 5.86M 6.37M 8.46M
Research & Development 3.37M 4.16M 4.27M 4.29M 5.13M
Other SG&A 1.64M 1.75M 1.6M 2.08M 3.32M
Other Operating Expense 0 0 0 0 0
Unusual Expense (192,763) 62,049 172,245 1.25M 1.95M
EBIT after Unusual Expense 192,763 (62,049) (172,245) (1.25M) (1.95M)
Non Operating Income/Expense 162,524 0 0 0 0
Non-Operating Interest Income 2,980 14,339 46,787 55,587 171,001
Equity in Affiliates (Pretax) 0 0 - 0 -
Interest Expense 0 0 0 1.09M 3.66M
Gross Interest Expense 0 0 0 1.09M 3.66M
Interest Capitalized 0 0 0 0 0
Pretax Income (4.74M) (6.48M) (6.21M) (8.88M) (14.11M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income (4.74M) (6.48M) (6.21M) (8.88M) (14.11M)
Minority Interest Expense 0 0 0 0 0
Net Income (4.74M) (6.48M) (6.21M) (8.88M) (14.11M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (4.74M) (6.48M) (6.21M) (8.88M) (14.11M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (4.74M) (6.48M) (6.21M) (8.88M) (14.11M)
EPS (Basic) (0.14) (0.18) (0.14) (0.67) (0.28)
Basic Shares Outstanding 37.29M 39.77M 42.76M 13.11M 51.23M
EPS (Diluted) (0.14) (0.18) (0.14) (0.67) (0.28)
Diluted Shares Outstanding 37.29M 39.77M 42.76M 13.11M 51.23M
EBITDA (5.01M) (5.9M) (5.86M) (6.37M) (8.46M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.